valproic acid has been researched along with rg108 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corey, DR; Sakurai, F; Yu, D | 1 |
| Blasiak, J; Kaarniranta, K; Tokarz, P | 1 |
2 other study(ies) available for valproic acid and rg108
| Article | Year |
|---|---|
Clonal Rett Syndrome cell lines to test compounds for activation of wild-type MeCP2 expression.
Topics: Clone Cells; Epigenesis, Genetic; Fibroblasts; Gene Expression Profiling; Humans; Methyl-CpG-Binding Protein 2; Molecular Structure; Mutation; Organic Chemicals; Polymerase Chain Reaction; Rett Syndrome; RNA, Messenger; Stereoisomerism | 2011 |
Inhibition of DNA methyltransferase or histone deacetylase protects retinal pigment epithelial cells from DNA damage induced by oxidative stress by the stimulation of antioxidant enzymes.
Topics: Antioxidants; Cell Line; DNA (Cytosine-5-)-Methyltransferases; DNA Damage; DNA Repair; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; M Phase Cell Cycle Checkpoints; Oxidative Stress; Phthalimides; Reactive Oxygen Species; Retinal Pigment Epithelium; Time Factors; Tryptophan; Valproic Acid | 2016 |